Pharmacists Raise Concerns for Patient Access to Generic Drugs

Share this content:
Pharmacists Raise Concerns for Patient Access to Generic Drugs
Pharmacists Raise Concerns for Patient Access to Generic Drugs

(HealthDay News) -- Nearly all pharmacists have experienced upswings in the acquisition costs of generic drugs, with price spikes reported to be worse since 2013, according to a report published by the National Community Pharmacists Association (NCPA).

In a survey of 700 community pharmacists, almost all pharmacists reported experiencing a large upswing in the acquisition cost of a generic drug over the past six months. Most pharmacists (93.4 percent) reported that the situation had gotten worse since 2013.

Most pharmacists report that it takes third-party payers one month or more to update pharmacy reimbursement rates accordingly (one to two months, 24.7 percent; three months or more, 62.3 percent). Most (92.8 percent) pharmacists report that the situation has gotten worse with respect to absorbing financial losses on these prescriptions. The typical response on appeal to pharmacy benefit management is rejection of appeal (56.9 percent), with no response in 25.9 percent of cases.

"This survey finds that this problem has only grown more severe over the past two years and requires urgent attention from federal and state policymakers," B. Douglas Hoey, R.Ph., M.B.A., chief executive officer of the NCPA, said in a statement. "Some patients are already skipping medication due to higher prices and copays or are forced into the Medicare coverage gap or 'donut hole' sooner."

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »